81 FR 9207 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 36 (February 24, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 36 (February 24, 2016)
| Page Range | 9207-9208 | |
| FR Document | 2016-03784 |
[Federal Register Volume 81, Number 36 (Wednesday, February 24, 2016)] [Notices] [Pages 9207-9208] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-03784] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Pulmonary, Cardiovascular and Musculoskeletal Epidemiology. Date: March 15, 2016. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892, (301) 435- 1712, ryansj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Drug Discovery for the Nervous System. Date: March 15, 2016. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Geoffrey G Schofield, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040-A, MSC 7850, Bethesda, MD 20892, 301-435-1235, geoffreys@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, AIDS and AIDS Related Applications. Date: March 17, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, Bethesda, MD 20892, 301-451-5953, tuoj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Computational, Modeling, and Biodata Management. Date: March 17-18, 2016. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-379- 9351, allen.richon@nih.hhs.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business PAR Panel: Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings. Date: March 17, 2016. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Firrell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD 20892, 301-435- 2598, firrellj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Cancer Diagnostics and Treatments (CDT). Date: March 21-22, 2016. Time: 8:00 a.m. to 5:00 p.m. [[Page 9208]] Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Zhang-Zhi Hu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6186, MSC 7804, Bethesda, MD 20892, (301) 594- 2414, huzhuang@csr.nih.gov. Name of Committee: Biology of Development and Aging Integrated Review Group, International and Cooperative Projects--1 Study Section. Date: March 21, 2016. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Hilary D Sigmon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD 20892, (301) 594-6377, sigmonh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Molecular and Cellular Causal Aspects of Alzheimer's Disease. Date: March 21, 2016. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Westin Grand, 2350 M Street NW., Washington, DC 20037. Contact Person: Mary Custer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435- 1164, custerm@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 18, 2016. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-03784 Filed 2-23-16; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 81, No. 36 / Wednesday, February 24, 2016 / Notices 9207
amended (5 U.S.C. App.), notice is Special Emphasis Panel, Ancillary Studies in MSC 7770, Bethesda, MD 20892, (301) 435–
hereby given of the following meetings. GI. 1712, ryansj@csr.nih.gov.
The meetings will be closed to the Date: April 6, 2016. Name of Committee: Center for Scientific
public in accordance with the Time: 10:30 a.m. to 1:00 p.m. Review Special Emphasis Panel, Member
Agenda: To review and evaluate grant Conflict: Drug Discovery for the Nervous
provisions set forth in sections applications. System.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: National Institutes of Health, Two Date: March 15, 2016.
as amended. The grant applications and Democracy Plaza, 6707 Democracy Time: 1:00 p.m. to 4:00 p.m.
the discussions could disclose Boulevard, Bethesda, MD 20892, (Telephone Agenda: To review and evaluate grant
confidential trade secrets or commercial Conference Call). applications.
property such as patentable material, Contact Person: Maria E. Davila-Bloom, Place: National Institutes of Health, 6701
and personal information concerning Ph.D., Scientific Review Officer, Review Rockledge Drive, Bethesda, MD 20892,
individuals associated with the grant Branch, DEA, NIDDK, National Institutes of (Telephone Conference Call).
applications, the disclosure of which Health, Room 758, 6707 Democracy Contact Person: Geoffrey G Schofield,
Boulevard, Bethesda, MD 20892–5452, (301) Ph.D., Scientific Review Officer, Center for
would constitute a clearly unwarranted 594–7637, davila-bloomm@ Scientific Review, National Institutes of
invasion of personal privacy. extra.niddk.nih.gov. Health, 6701 Rockledge Drive, Room 4040–A,
Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance MSC 7850, Bethesda, MD 20892, 301–435–
Diabetes and Digestive and Kidney Diseases Program Nos. 93.847, Diabetes, 1235, geoffreys@csr.nih.gov.
Special Emphasis Panel, NIDDK Ancillary Endocrinology and Metabolic Research; Name of Committee: Center for Scientific
Studies. 93.848, Digestive Diseases and Nutrition Review Special Emphasis Panel, AIDS and
Date: March 14, 2016. Research; 93.849, Kidney Diseases, Urology AIDS Related Applications.
Time: 1:00 p.m. to 2:00 p.m. and Hematology Research, National Institutes Date: March 17, 2016.
Agenda: To review and evaluate grant of Health, HHS) Time: 8:00 a.m. to 5:00 p.m.
applications. Agenda: To review and evaluate grant
Place: National Institutes of Health, Two Dated: February 18, 2016.
applications.
Democracy Plaza, 6707 Democracy David Clary, Place: Hyatt Regency Bethesda, One
Boulevard, Bethesda, MD 20892, (Telephone Program Analyst, Office of Federal Advisory Bethesda Metro Center, 7400 Wisconsin
Conference Call). Committee Policy. Avenue, Bethesda, MD 20814.
Contact Person: Elena Sanovich, Ph.D., [FR Doc. 2016–03779 Filed 2–23–16; 8:45 am] Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Review Branch, Scientific Review Officer, Center for
BILLING CODE 4140–01–P
DEA, NIDDK, National Institutes of Health, Scientific Review, National Institutes of
Room 750, 6707 Democracy Boulevard, Health, 6701 Rockledge Drive, Room 3196,
Bethesda, MD 20892–2542, 301–594–8886, Bethesda, MD 20892, 301–451–5953, tuoj@
sanoviche@mail.nih.gov. DEPARTMENT OF HEALTH AND csr.nih.gov.
HUMAN SERVICES
Name of Committee: National Institute of Name of Committee: Center for Scientific
Diabetes and Digestive and Kidney Diseases Review Special Emphasis Panel, Small
National Institutes of Health
Special Emphasis Panel, PAR–13–305 Business: Computational, Modeling, and
Collaborative Interdisciplinary Team Science Biodata Management.
Center for Scientific Review; Notice of
(R24): Beta Cell Failure. Date: March 17–18, 2016.
Date: March 22, 2016. Closed Meetings Time: 10:00 a.m. to 5:00 p.m.
Time: 2:00 p.m. to 4:00 p.m. Pursuant to section 10(d) of the Agenda: To review and evaluate grant
Agenda: To review and evaluate grant Federal Advisory Committee Act, as applications.
applications. Place: National Institutes of Health, 6701
Place: National Institutes of Health, Two
amended (5 U.S.C. App.), notice is Rockledge Drive, Bethesda, MD 20892.
Democracy Plaza, 6707 Democracy hereby given of the following meetings. Contact Person: Allen Richon, Ph.D.,
Boulevard, Bethesda, MD 20892, (Telephone The meetings will be closed to the Scientific Review Officer, Center for
Conference Call). public in accordance with the Scientific Review, National Institutes of
Contact Person: Ann A. Jerkins, Ph.D., provisions set forth in sections Health, 6701 Rockledge Drive, Room 6184,
Scientific Review Officer, Review Branch, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7892, Bethesda, MD 20892, 301–379–
DEA, NIDDK, National Institutes of Health, as amended. The grant applications and 9351, allen.richon@nih.hhs.gov.
Room 759, 6707 Democracy Boulevard, the discussions could disclose Name of Committee: Center for Scientific
Bethesda, MD 20892–5452, 301–594–2242, confidential trade secrets or commercial Review Special Emphasis Panel, Small
jerkinsa@niddk.nih.gov. property such as patentable material, Business PAR Panel: Safe and Effective
Name of Committee: National Institute of and personal information concerning Instruments and Devices for Use in Neonatal
Diabetes and Digestive and Kidney Diseases and Pediatric Care Settings.
individuals associated with the grant
Special, Emphasis Panel, PAR–13–305 Date: March 17, 2016.
Collaborative Interdisciplinary Team Science
applications, the disclosure of which Time: 11:00 a.m. to 5:00 p.m.
(R24): Skeletal, Muscle and Diabetes. would constitute a clearly unwarranted Agenda: To review and evaluate grant
Date: March 28, 2016. invasion of personal privacy. applications.
Time: 1:00 p.m. to 3:00 p.m. Name of Committee: Center for Scientific Place: National Institutes of Health, 6701
Agenda: To review and evaluate grant Review Special Emphasis Panel, Member Rockledge Drive, Bethesda, MD 20892,
applications. Conflict: Pulmonary, Cardiovascular and (Virtual Meeting).
Place: National Institutes of Health, Two Musculoskeletal Epidemiology. Contact Person: John Firrell, Ph.D.,
Democracy Plaza, 6707 Democracy Date: March 15, 2016. Scientific Review Officer, Center for
Boulevard, Bethesda, MD 20892, (Telephone Time: 11:00 a.m. to 1:00 p.m. Scientific Review, National Institutes of
Conference Call). Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 5118,
mstockstill on DSK4VPTVN1PROD with NOTICES
Contact Person: Ann A. Jerkins, Ph.D., applications. MSC 7854, Bethesda, MD 20892, 301–435–
Scientific Review Officer, Review Branch, Place: National Institutes of Health, 6701 2598, firrellj@csr.nih.gov.
DEA, NIDDK, National Institutes of Health, Rockledge Drive, Bethesda, MD 20892, Name of Committee: Center for Scientific
Room 759, 6707 Democracy Boulevard, (Telephone Conference Call). Review Special Emphasis Panel, Small
Bethesda, MD 20892–5452, 301–594–2242, Contact Person: Suzanne Ryan, Ph.D., Business: Cancer Diagnostics and Treatments
jerkinsa@niddk.nih.gov. Scientific Review Officer, Center for (CDT).
Name of Committee: National Institute of Scientific Review, National Institutes of Date: March 21–22, 2016.
Diabetes and Digestive and Kidney Diseases Health, 6701 Rockledge Drive, Room 3139, Time: 8:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014 17:59 Feb 23, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1](https://thefederalregister.org/doc/81_FR_9243/page/1.svg)
![9208 Federal Register / Vol. 81, No. 36 / Wednesday, February 24, 2016 / Notices
Agenda: To review and evaluate grant as amended. The grant applications and Name of Committee: Center for Scientific
applications. the discussions could disclose Review Special Emphasis Panel, Member
Place: Embassy Suites at the Chevy Chase confidential trade secrets or commercial Conflict: Corneal and Retinal Biopathologies.
Pavilion, 4300 Military Road NW., property such as patentable material, Date: March 3, 2016.
Washington, DC 20015. Time: 8:30 a.m. to 5:00 p.m.
Contact Person: Zhang-Zhi Hu, MD,
and personal information concerning
Agenda: To review and evaluate grant
Scientific Review Officer, Center for individuals associated with the grant applications.
Scientific Review, National Institutes of applications, the disclosure of which Place: National Institutes of Health, 6701
Health, 6701 Rockledge Drive, Room 6186, would constitute a clearly unwarranted Rockledge Drive, Bethesda, MD 20892.
MSC 7804, Bethesda, MD 20892, (301) 594– invasion of personal privacy. Contact Person: Samuel C Edwards, Ph.D.,
2414, huzhuang@csr.nih.gov. Name of Committee: National Cancer IRG CHIEF, Center for Scientific Review,
Name of Committee: Biology of Institute Special Emphasis Panel: Provocative National Institutes of Health, 6701 Rockledge
Development and Aging Integrated Review Question on Microbiota and Responses to Drive, Room 5210, MSC 7846, Bethesda, MD
Group, International and Cooperative Cancer Therapies. 20892, (301) 435–1246, edwardss@
Projects—1 Study Section. Date: March 21, 2016. csr.nih.gov.
Date: March 21, 2016. Time: 12:00 p.m. to 3:00 p.m. This notice is being published less than 15
Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant days prior to the meeting due to the timing
Agenda: To review and evaluate grant applications. limitations imposed by the review and
applications. Place: National Cancer Institute Shady funding cycle.
Place: National Institutes of Health, 6701 Grove, 9609 Medical Center Drive, Room
Rockledge Drive, Bethesda, MD 20892. Name of Committee: Center for Scientific
7W554, Rockville, MD 20850 (Telephone
Contact Person: Hilary D Sigmon, Ph.D., Review Special Emphasis Panel, Member
Conference Call).
Scientific Review Officer, Center for Conflict: Blood Formation.
Contact Person: Christopher L. Hatch,
Scientific Review, National Institutes of Date: March 3, 2016.
Ph.D., Chief, Program Coordination &
Health, 6701 Rockledge Drive, Room 5222, Time: 3:00 p.m. to 5:00 p.m.
Referral Branch, Division of Extramural
MSC 7852, Bethesda, MD 20892, (301) 594– Agenda: To review and evaluate grant
Activities, National Cancer Institute, NIH,
6377, sigmonh@csr.nih.gov. 9609 Medical Center Drive, Room 7W554, applications.
Name of Committee: Center for Scientific Rockville, MD 20850, 240–276–6454, ch29v@ Place: National Institutes of Health, 6701
Review Special Emphasis Panel, Molecular nih.gov. Rockledge Drive, Bethesda, MD 20892,
and Cellular Causal Aspects of Alzheimer’s (Telephone Conference Call).
(Catalogue of Federal Domestic Assistance Contact Person: Luis Espinoza, Ph.D.,
Disease. Program Nos. 93.392, Cancer Construction;
Date: March 21, 2016. Scientific Review Officer, Center for
93.393, Cancer Cause and Prevention
Time: 2:00 p.m. to 3:00 p.m. Scientific Review, National Institutes of
Research; 93.394, Cancer Detection and
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 4140,
Diagnosis Research; 93.395, Cancer
applications. MSC 7814, Bethesda, MD 20892, 301–435–
Treatment Research; 93.396, Cancer Biology
Place: Westin Grand, 2350 M Street NW., 0952, espinozala@mail.nih.gov.
Research; 93.397, Cancer Centers Support;
Washington, DC 20037. 93.398, Cancer Research Manpower; 93.399, This notice is being published less than 15
Contact Person: Mary Custer, Ph.D., Cancer Control, National Institutes of Health, days prior to the meeting due to the timing
Scientific Review Officer, Center for HHS) limitations imposed by the review and
Scientific Review, National Institutes of funding cycle.
Health, 6701 Rockledge Drive, Room 4148, Dated: February 18, 2016.
Name of Committee: Center for Scientific
MSC 7850, Bethesda, MD 20892, (301) 435– Melanie J. Gray, Review Special Emphasis Panel, Member
1164, custerm@csr.nih.gov. Program Analyst, Office of Federal Advisory Conflict: Cancer Immunopathology and
(Catalogue of Federal Domestic Assistance Committee Policy. Immunotherapy.
Program Nos. 93.306, Comparative Medicine; [FR Doc. 2016–03786 Filed 2–23–16; 8:45 am] Date: March 8, 2016.
93.333, Clinical Research, 93.306, 93.333, BILLING CODE 4140–01–P Time: 1:00 p.m. to 3:00 p.m.
93.337, 93.393–93.396, 93.837–93.844, Agenda: To review and evaluate grant
93.846–93.878, 93.892, 93.893, National applications.
Institutes of Health, HHS) Place: National Institutes of Health, 6701
DEPARTMENT OF HEALTH AND
Dated: February 18, 2016. Rockledge Drive, Bethesda, MD 20892,
HUMAN SERVICES
(Telephone Conference Call).
Carolyn Baum,
Contact Person: Sharon K Gubanich, Ph.D.,
Program Analyst, Office of Federal Advisory National Institutes of Health
Scientific Review Officer, Center for
Committee Policy. Scientific Review, National Institutes of
Center for Scientific Review; Notice of
[FR Doc. 2016–03784 Filed 2–23–16; 8:45 am] Health, 6701 Rockledge Drive, Room 6195D,
Closed Meetings MSC 7804, Bethesda, MD 20892, (301) 408–
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the 9512, gubanics@csr.nih.gov.
Federal Advisory Committee Act, as This notice is being published less than 15
DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is days prior to the meeting due to the timing
HUMAN SERVICES hereby given of the following meetings. limitations imposed by the review and
The meetings will be closed to the funding cycle.
National Institutes of Health public in accordance with the (Catalogue of Federal Domestic Assistance
provisions set forth in sections Program Nos. 93.306, Comparative Medicine;
National Cancer Institute Notice of 93.333, Clinical Research, 93.306, 93.333,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Closed Meetings 93.337, 93.393–93.396, 93.837–93.844,
as amended. The grant applications and 93.846–93.878, 93.892, 93.893, National
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the the discussions could disclose Institutes of Health, HHS)
Federal Advisory Committee Act, as confidential trade secrets or commercial
property such as patentable material, Dated: February 18, 2016.
amended (5 U.S.C. App.), notice is
hereby given of the following meeting. and personal information concerning Carolyn Baum,
The meeting will be closed to the individuals associated with the grant Program Analyst, Office of Federal Advisory
public in accordance with the applications, the disclosure of which Committee Policy.
provisions set forth in sections would constitute a clearly unwarranted [FR Doc. 2016–03783 Filed 2–23–16; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy. BILLING CODE 4140–01–P
VerDate Sep<11>2014 17:59 Feb 23, 2016 Jkt 238001 PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 E:\FR\FM\24FEN1.SGM 24FEN1](https://thefederalregister.org/doc/81_FR_9243/page/2.svg)
Document Created: 2016-02-23 23:55:34
Document Modified: 2016-02-23 23:55:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | March 15, 2016. | |
| FR Citation | 81 FR 9207 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR